Cargando…
SCF(β-TrCP)-mediated degradation of TOP2β promotes cancer cell survival in response to chemotherapeutic drugs targeting topoisomerase II
Topoisomerase II (TOP2)-targeting anticancer chemotherapeutic drugs, termed TOP2 poisons, are widely used and effective in the clinic by stabilizing TOP2-DNA covalent complexes to induce DNA double-strand breaks (DSBs) and ultimately, cause cell death. The stabilized TOP2-DNA complex is known to be...
Autores principales: | Shu, Jianfeng, Cui, Danrui, Ma, Ying, Xiong, Xiufang, Sun, Yi, Zhao, Yongchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997367/ https://www.ncbi.nlm.nih.gov/pubmed/32015321 http://dx.doi.org/10.1038/s41389-020-0196-1 |
Ejemplares similares
-
SCFβ‐TrCP ubiquitinates CHK1 in an AMPK‐dependent manner in response to glucose deprivation
por: Ma, Ying, et al.
Publicado: (2018) -
The cross talk of two family members of β-TrCP in the regulation of cell autophagy and growth
por: Cui, Danrui, et al.
Publicado: (2019) -
SCF(βTrCP)-mediated degradation of SHARP1 in triple-negative breast cancer
por: Enriqué Steinberg, Juliana Haydeé, et al.
Publicado: (2023) -
Datasets from an interaction proteomics screen for substrates of the SCF(βTrCP) ubiquitin ligase
por: Magliozzi, Roberto, et al.
Publicado: (2015) -
Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction
por: Jaffry, Uzma, et al.
Publicado: (2023)